世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

遠隔医療・遠隔診断市場:コンポーネント(ソフトウェア&サービス(RPM、リアルタイム)、ハードウェア(モニター))、デリバリー(オンプレミス、クラウドベース)、アプリケーション(Telleradiology、Telestroke、TelICU)、エンドユーザー(プロバイダー、ペイヤー)、地域別 - 2027年までの世界市場予測


Telehealth & Telemedicine Market by Component (Software & Services (RPM, Real-Time), Hardware (Monitors)), Delivery (On-Premise, Cloud-Based), Application (Teleradiology, Telestroke, TeleICU), End User (Provider, Payer) & Region - Global Forecasts to 2027

世界の遠隔医療・健康管理市場は、予測期間中にCAGR26.6%で成長し、2022年の推定878億米ドルから2027年には2857億米ドルに達すると予測されています。この市場の成長を促す主な要因としては、医療アクセス拡大の... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 図表数 言語
MarketsandMarkets
マーケッツアンドマーケッツ
2022年3月10日 US$4,950
シングルユーザライセンス
ライセンス・価格情報・注文方法はこちら
284 335 英語

日本語のページは自動翻訳を利用し作成しています。


 

サマリー

世界の遠隔医療・健康管理市場は、予測期間中にCAGR26.6%で成長し、2022年の推定878億米ドルから2027年には2857億米ドルに達すると予測されています。この市場の成長を促す主な要因としては、医療アクセス拡大の必要性、慢性疾患や症状の蔓延、医師不足、通信技術の進歩、政府の支援と意識向上、COVID-19をきっかけとした技術導入の増加などが挙げられます。ただし、規制の地域差、不正行為、ケア提供者のソーシャルメディアの利用などが、予測期間中の市場成長を制限することになるでしょう。

"ソフトウェア&サービス分野は予測期間中に最も高い成長率を示すだろう"
遠隔医療市場は構成要素に基づき、ソフトウェア&サービス分野とハードウェア分野に分類されます。2021年のテレヘルス市場では、ソフトウェア&セグメントが最大のシェアを占めています。このセグメントの大きなシェアは、主に世界中でテレヘルスと遠隔医療の導入が進んでいることに起因しています。ハードウェアセグメントは、予測期間中に27.8%という最高のCAGRを記録すると予測されています。

"配信モード別では、2021年の遠隔医療市場でクラウドベースセグメントが最大のシェアを占めました。"
配信モードに基づき、世界の遠隔医療市場は、クラウドベースセグメントとオンプレミスセグメントに区分されます。2021年の遠隔健康市場では、人体病理学セグメントが最大のシェアを占めています。クラウドベースの配信モードセグメントの市場を牽引する主な要因は、サービスのオンデマンド性、拡張性の容易さ、クラウドベースのソリューションのコスト削減性などです。


"予測期間中、アジア太平洋地域の市場が最も高い成長を遂げると予測される"
アジア太平洋地域は、予測期間中に最も高い成長を記録すると予測されています。この大きなシェアは、慢性疾患の増加、医療費削減の必要性、全人口および老年人口の増加などの要因に起因しています。

一次面接の内訳。
- 企業タイプ別(供給側)。Tier1:29%、Tier2:37%、Tier3:34%。
- カテゴリー別(需要側):病院。55%、クリニック/独立系医師35%、ペイヤー:10
- 役職別Cレベルエグゼクティブ35%、ディレクターレベル:25%、マネージャー:40
- 地域別北米:35%、欧州:32%、アジア:22%、RoW:11

Koninklijke Philips(オランダ)、Medtronic(アイルランド)、GE Healthcare(米国)が世界の遠隔医療市場の主要企業である。その他、サーナー・コーポレーション(米国)、シーメンス・ヘルスマイヤーズ(ドイツ)、シスコシステムズ(米国)、旭化成株式会社(日本)、テラドックヘルス(米国)、アメリカンウェル(米国)、AMCヘルス(米国)、MDLIVE(米国)、ドクターオンデマンド(米国)、メドビボ(英国)などが注目企業として挙げられる。Iron Bow Technologies(米国)、TeleSpecialists(米国)、GlobalMed(米国)、Medweb(米国)、IMEDIPLUS(台湾)、VSee(米国)、Chiron Health(米国)、Zipnosis(米国)、ALTEN Calsoft Labs(米国)、iCliniq(インド)、Preventice Solutions(米国)、Resideo Life Care Solutions(米国)の6社があります。

調査範囲
本レポートでは、遠隔健康・遠隔医療市場を構成要素、提供形態、用途、エンドユーザー、地域に基づいて分析しています。また、市場成長に影響を与える要因(ドライバー、阻害要因、機会、課題など)についても調査しています。市場における機会や課題を分析し、市場リーダー向けの競争環境の詳細を提供しています。さらに、ミクロ市場を個々の成長傾向に関して分析し、異なる地域に関して市場セグメントの収益を予測します。
レポート購入の主なメリット
本レポートでは、様々なレベルの分析-産業動向、トッププレイヤーの市場シェア、企業プロファイル-に焦点を当て、これらを合わせて基本的な見解を形成し、競争環境、高成長地域とそのドライバー、阻害要因、課題、機会について分析します。本レポートは、既存企業だけでなく新規参入企業や中小企業にとっても、市場の動向を把握し、より大きな市場シェアを獲得するために役立つものです。

 

ページTOPに戻る


 

Summary

The global telehealth & telemedicine market is expected to grow at a CAGR of 26.6% during the forecast period, to reach USD 285.7 billion by 2027 from an estimated USD 87.8 billion in 2022. The key factors driving the growth of this market include the need to expand healthcare access, the growing prevalence of chronic diseases and conditions, a shortage of physicians, advancements in telecommunications, government support and raising awareness, and rising technology adoption in the wake of COVID-19. However, regional variations in regulations, fraud, and the use of social media for care providers will restrict the market growth during the forecast period.

“The software & services segment will grow at the highest rate during the forecast period.”
Based on components, the telehealth market is segmented into software & services and hardware segment. The software & segment accounted for the largest share of the telehealth market in 2021. The large share of this segment is mainly due to the increasing adoption of telehealth and telemedicine across the globe. The hardware segment is projected to register the highest CAGR of 27.8% during the forecast period.

“By delivery mode, the cloud-based segment accounted for the largest share of the telehealth market in 2021.”
Based on the mode of delivery, the global telehealth market is segmented into cloud-based and on-premise segments. The human pathology segment accounted for the largest share of the telehealth market in 2021. The major factors driving the market for cloud-based delivery mode segments are the on-demand nature of the services, their easy scalability, and the costs-curtailing nature of cloud-based solutions.


“The market in Asia Pacific is projected to witness the highest growth during the forecast period.”
Asia Pacific is projected to register the highest growth during the forecast period. This large share can be attributed to factors such as the rising prevalence of chronic conditions, the need to reduce healthcare expenditure, increasing overall and geriatric population.

Breakdown of Primary Interviews:
• By Company Type (Supply-side): Tier 1: 29%, Tier 2: 37%, and Tier 3: 34%
• By Category (Demand-side): Hospitals: 55%, Clinics/Independent Physicians: 35%, and Payers: 10%
• By Designation: C-level executives: 35%, Director-level: 25%, and Managers: 40%
• By Region: North America: 35%, Europe: 32%, Asia: 22%, and the RoW: 11%

Koninklijke Philips (Netherlands), and Medtronic (Ireland), GE Healthcare (US) are the leading players in the global telehealth market. Other notable players in this market include Cerner Corporation (US), Siemens Healthineers (Germany), Cisco Systems (US), Asahi Kasei Corporation (Japan), Teladoc Health (US), American Well (US), AMC Health (US), MDLIVE (US), Doctor on Demand (US), Medvivo (UK), Iron Bow Technologies (US), TeleSpecialists (US), GlobalMed (US), Medweb (US), IMEDIPLUS (Taiwan), VSee (US), Chiron Health (US), Zipnosis (US), ALTEN Calsoft Labs (US), iCliniq (India), Preventice Solutions (US), and Resideo Life Care Solutions (US).

Research Coverage
The report analyzes the telehealth & telemedicine market based on component, mode of delivery, application, end user, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes the opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends and forecasts revenue of the market segments with respect to different geographies.
Key Benefits of Buying the Report
The report focuses on various levels of analysis—industry trends, market share of top players, and company profiles, which together form basic views and analyze the competitive landscape, and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.



ページTOPに戻る


Table of Contents

1 INTRODUCTION 38
1.1 OBJECTIVES OF THE STUDY 38
1.2 MARKET DEFINITION 38
1.2.1 INCLUSIONS AND EXCLUSIONS 39
1.2.2 MARKET SEGMENTATION 39
1.2.3 YEARS CONSIDERED FOR THE STUDY 40
1.3 CURRENCY 40
1.4 LIMITATIONS 40
1.5 STAKEHOLDERS 41
1.6 SUMMARY OF CHANGES 41
2 RESEARCH METHODOLOGY 43
2.1 RESEARCH DATA 43
2.2 RESEARCH METHODOLOGY STEPS 43
FIGURE 1 RESEARCH METHODOLOGY: TELEHEALTH AND TELEMEDICINE MARKET 43
FIGURE 2 RESEARCH DESIGN 44
2.2.1 SECONDARY DATA 44
2.2.1.1 Secondary sources 45
2.2.2 PRIMARY DATA 46
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY CATEGORY, DESIGNATION, 
AND REGION 47
2.2.2.1 Primary sources 47
2.2.2.2 Key insights from primary sources 47
2.3 MARKET SIZE ESTIMATION 48
FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 48
FIGURE 5 ESTIMATION OF THE MARKET SIZE FOR REMOTE PATIENT MONITORING SOFTWARE & SERVICES THROUGH THE ADOPTION-BASED APPROACH 49
FIGURE 6 ESTIMATION OF THE MARKET SIZE FOR REAL-TIME INTERACTION SOFTWARE & SERVICES THROUGH THE ADOPTION-BASED APPROACH 49
FIGURE 7 ESTIMATION OF THE MARKET SIZE FOR STORE-AND-FORWARD SOFTWARE & SERVICES THROUGH THE ADOPTION-BASED APPROACH 50
FIGURE 8 ESTIMATION OF THE GLOBAL TELEHEALTH AND TELEMEDICINE MARKET SIZE THROUGH THE ADOPTION-BASED APPROACH 50
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 52
FIGURE 9 DATA TRIANGULATION METHODOLOGY 52
2.5 ASSUMPTIONS FOR THE STUDY 53
2.6 COVID-19 SPECIFIC ASSUMPTIONS 53
2.7 RISK ASSESSMENT 53
3 EXECUTIVE SUMMARY 54
FIGURE 10 TELEHEALTH AND TELEMEDICINE MARKET ANALYSIS, BY MODE OF DELIVERY (2022) 54
FIGURE 11 TELEHEALTH AND TELEMEDICINE MARKET, BY COMPONENT, 
2022 VS. 2027 (USD MILLION) 55
FIGURE 12 TELEHEALTH AND TELEMEDICINE MARKET, BY APPLICATION, 
2022 VS. 2027, (USD MILLION) 55
FIGURE 13 TELEHEALTH AND TELEMEDICINE MARKET, BY END USER, 
2022 (USD MILLION) 56
FIGURE 14 ASIA PACIFIC TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD 57
4 PREMIUM INSIGHTS 58
4.1 TELEHEALTH AND TELEMEDICINE MARKET OVERVIEW 58
FIGURE 15 SHORTAGE OF PHYSICIANS, RISING PREVALENCE OF CHRONIC CONDITIONS, AND INCREASE IN AGING POPULATION DRIVE MARKET GROWTH 58
4.2 NORTH AMERICA: TELEHEALTH AND TELEMEDICINE MARKET, BY COMPONENT (2021) 59
FIGURE 16 SOFTWARE & SERVICES SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN TELEHEALTH AND TELEMEDICINE MARKET IN 2021 59
4.3 TELEHEALTH AND TELEMEDICINE MARKET, BY APPLICATION, 2022 VS. 2027 59
FIGURE 17 TELERADIOLOGY TO DOMINATE THE APPLICATION SEGMENT IN 2022 59
4.4 GEOGRAPHIC SNAPSHOT OF THE TELEHEALTH AND TELEMEDICINE MARKET 60
FIGURE 18 ASIA PACIFIC TO WITNESS THE HIGHEST GROWTH IN THE TELEHEALTH AND TELEMEDICINE MARKET FROM 2022 TO 2027 60
5 MARKET OVERVIEW 61
5.1 INTRODUCTION 61
5.2 MARKET DYNAMICS 61
FIGURE 19 TELEHEALTH AND TELEMEDICINE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 61
5.2.1 DRIVERS 62
5.2.1.1 Growing geriatric population and need to expand healthcare access 62
TABLE 1 GLOBAL OVERVIEW OF THE RISE IN AGING POPULATION (MILLION) 62
5.2.1.2 Rising prevalence of chronic conditions and cost-benefits of telehealth and telemedicine 63
TABLE 2 CHRONIC DISEASES AND THEIR COST BURDEN IN THE US: POTENTIAL FOR SAVINGS 63
5.2.1.3 Shortage of physicians 63
5.2.1.4 Advancements in telecommunications 64
5.2.1.5 Government support and rising awareness 64
5.2.1.6 Technology adoption in the wake of the COVID-19 pandemic 65
TABLE 3 TOTAL NUMBER OF CONFIRMED CORONAVIRUS CASES, BY REGION (AS OF JANUARY 7, 2022) 65
TABLE 4 HEALTHCARE IOT: USE CASES 66
5.2.1.7 Private and public support for COVID-19 management 66
5.2.2 RESTRAINTS 67
5.2.2.1 Regulatory variations across regions 67
TABLE 5 US: STATE-WISE REGULATORY OUTLOOK FOR TELEHEALTH 67
5.2.2.2 Fraud in telemedicine and telehealth 68
5.2.2.3 Use of social media 68
5.2.3 OPPORTUNITIES 69
5.2.3.1 High utility in combating infectious diseases and epidemics 69
5.2.3.2 Use of blockchain 69
5.2.3.3 AI and analytics 70
5.2.3.4 Virtual assistants 70
5.2.4 CHALLENGES 71
5.2.4.1 Inability to ascertain hygiene and cleanliness 71
5.2.4.2 Behavioral barriers, healthcare affordability, and lack of awareness 71
5.3 IMPACT OF COVID-19 ON THE TELEHEALTH AND TELEMEDICINE MARKET 72
5.4 VALUE CHAIN ANALYSIS 73
FIGURE 20 TELEHEALTH AND TELEMEDICINE MARKET: VALUE CHAIN 74
5.5 ECOSYSTEM ANALYSIS 74
FIGURE 21 TELEHEALTH AND TELEMEDICINE MARKET: ECOSYSTEM 78
5.6 PRICING & REIMBURSEMENT ANALYSIS 79
TABLE 6 MEDICARE TELEMEDICINE SERVICES AND HCPCS/CPT CODES 80
5.7 TECHNOLOGY ANALYSIS 81
5.7.1 MACHINE LEARNING 81
5.7.2 ARTIFICIAL INTELLIGENCE 82
5.7.3 INTERNET OF THINGS 82
5.7.4 BLOCKCHAIN 82
5.7.5 CLOUD COMPUTING 83
5.7.6 DATA ANALYTICS 83
5.7.7 EXTENDED REALITY 83
5.8 REGULATORY ANALYSIS 84
5.8.1 NORTH AMERICA 84
5.8.2 EUROPE 85
5.8.3 ASIA PACIFIC 85
5.8.4 MIDDLE EAST & AFRICA 86
5.8.5 LATIN AMERICA 86
5.9 KEY INDUSTRY TRENDS 87
5.10 OVERVIEW OF USE CASES 88
TABLE 7 OVERVIEW OF TELEHEALTH USE CASES 90
6 TELEHEALTH AND TELEMEDICINE MARKET, BY COMPONENT 92
6.1 INTRODUCTION 93
TABLE 8 TELEHEALTH AND TELEMEDICINE MARKET, BY COMPONENT, 
2020–2027 (USD MILLION) 93
6.2 SOFTWARE & SERVICES 93
TABLE 9 TELEHEALTH AND TELEMEDICINE SOFTWARE & SERVICES MARKET, 
BY REGION, 2020–2027 (USD MILLION) 93
TABLE 10 TELEHEALTH AND TELEMEDICINE SOFTWARE & SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 94
6.2.1 REMOTE PATIENT MONITORING 94
6.2.1.1 Convenience and high utility are driving the demand for remote monitoring services and devices 94
TABLE 11 REMOTE PATIENT MONITORING SOFTWARE & SERVICES MARKET, 
BY REGION, 2020–2027 (USD MILLION) 95
TABLE 12 NORTH AMERICA: REMOTE PATIENT MONITORING SOFTWARE & SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 96
TABLE 13 EUROPE: REMOTE PATIENT MONITORING SOFTWARE & SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 96
TABLE 14 ASIA PACIFIC: REMOTE PATIENT MONITORING SOFTWARE & SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 96
TABLE 15 ROW: REMOTE PATIENT MONITORING SOFTWARE & SERVICES MARKET, 
BY REGION, 2020–2027 (USD MILLION) 97
6.2.2 REAL-TIME INTERACTION 97
6.2.2.1 Synchronous nature and potential to increase healthcare access will drive the growth of this market segment 97
TABLE 16 REAL-TIME INTERACTION SOFTWARE & SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION) 98
TABLE 17 NORTH AMERICA: REAL-TIME INTERACTION SOFTWARE & SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 98
TABLE 18 EUROPE: REAL-TIME INTERACTION SOFTWARE & SERVICES MARKET, 
BY COUNTRY, 2020–2027 (USD MILLION) 98
TABLE 19 ASIA PACIFIC: REAL-TIME INTERACTION SOFTWARE & SERVICES MARKET, 
BY COUNTRY, 2020–2027 (USD MILLION) 99
TABLE 20 ROW: REAL-TIME INTERACTION SOFTWARE & SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION) 99
6.2.3 STORE AND FORWARD 99
6.2.3.1 Limited reimbursement scenario may affect market growth 99
TABLE 21 STORE AND FORWARD SOFTWARE & SERVICES MARKET, BY REGION, 
2020–2027 (USD MILLION) 100
TABLE 22 NORTH AMERICA: STORE AND FORWARD SOFTWARE & SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 100
TABLE 23 EUROPE: STORE AND FORWARD SOFTWARE & SERVICES MARKET, 
BY COUNTRY, 2020–2027 (USD MILLION) 101
TABLE 24 ASIA PACIFIC: STORE AND FORWARD SOFTWARE & SERVICES MARKET, 
BY COUNTRY, 2020–2027 (USD MILLION) 101
TABLE 25 ROW: STORE AND FORWARD SOFTWARE & SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION) 101
6.3 HARDWARE 102
TABLE 26 TELEHEALTH AND TELEMEDICINE HARDWARE MARKET, BY REGION, 
2020–2027 (USD MILLION) 102
TABLE 27 TELEHEALTH AND TELEMEDICINE HARDWARE MARKET, BY TYPE, 
2020–2027 (USD MILLION) 102
6.3.1 MONITORS 102
6.3.1.1 Increase in remote monitoring and telemedicine adoption will drive the requirement for monitors 102
TABLE 28 MONITORS MARKET, BY REGION, 2020–2027 (USD MILLION) 103
TABLE 29 NORTH AMERICA: MONITORS MARKET, BY COUNTRY, 
2020–2027 (USD MILLION) 103
TABLE 30 EUROPE: MONITORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 103
TABLE 31 ASIA PACIFIC: MONITORS MARKET, BY COUNTRY, 
2020–2027 (USD MILLION) 104
TABLE 32 ROW: MONITORS MARKET, BY REGION, 2020–2027 (USD MILLION) 104
6.3.2 MEDICAL PERIPHERAL DEVICES 104
TABLE 33 MEDICAL PERIPHERAL DEVICES MARKET, BY REGION, 
2020–2027 (USD MILLION) 105
TABLE 34 MEDICAL PERIPHERAL DEVICES MARKET, BY TYPE, 
2020–2027 (USD MILLION) 105
6.3.2.1 Blood pressure monitors 105
6.3.2.1.1 Convenience and growing demand have ensured high growth of this market segment 105
TABLE 35 BLOOD PRESSURE MONITORS MARKET, BY REGION, 
2020–2027 (USD MILLION) 106
TABLE 36 NORTH AMERICA: BLOOD PRESSURE MONITORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 106
TABLE 37 EUROPE: BLOOD PRESSURE MONITORS MARKET, BY COUNTRY, 
2020–2027 (USD MILLION) 106
TABLE 38 ASIA PACIFIC: BLOOD PRESSURE MONITORS MARKET, BY COUNTRY, 
2020–2027 (USD MILLION) 107
TABLE 39 ROW: BLOOD PRESSURE MONITORS MARKET, BY REGION, 
2020–2027 (USD MILLION) 107
6.3.2.2 Blood glucose meters 107
6.3.2.2.1 Growth in the diabetic population will ensure strong demand for blood glucose monitoring 107
TABLE 40 BLOOD GLUCOSE METERS MARKET, BY REGION, 2020–2027 (USD MILLION) 108
TABLE 41 NORTH AMERICA: BLOOD GLUCOSE METERS MARKET, BY COUNTRY, 
2020–2027 (USD MILLION) 108
TABLE 42 EUROPE: BLOOD GLUCOSE METERS MARKET, BY COUNTRY, 
2020–2027 (USD MILLION) 108
TABLE 43 ASIA PACIFIC: BLOOD GLUCOSE METERS MARKET, BY COUNTRY, 
2020–2027 (USD MILLION) 109
TABLE 44 ROW: BLOOD GLUCOSE METERS MARKET, BY REGION, 
2020–2027 (USD MILLION) 109
6.3.2.3 Weight scales 109
6.3.2.3.1 Increasing prevalence of obesity will ensure strong demand for weight scales 109
TABLE 45 WEIGHT SCALES MARKET, BY REGION, 2020–2027 (USD MILLION) 110
TABLE 46 NORTH AMERICA: WEIGHT SCALES MARKET, BY COUNTRY, 
2020–2027 (USD MILLION) 110
TABLE 47 EUROPE: WEIGHT SCALES MARKET, BY COUNTRY, 
2020–2027 (USD MILLION) 110
TABLE 48 ASIA PACIFIC: WEIGHT SCALES MARKET, BY COUNTRY, 
2020–2027 (USD MILLION) 111
TABLE 49 ROW: WEIGHT SCALES MARKET, BY REGION, 2020–2027 (USD MILLION) 111
6.3.2.4 Pulse oximeters 111
6.3.2.4.1 Rising awareness of self-monitoring and device convenience driving the demand for pulse oximeters 111
TABLE 50 PULSE OXIMETERS MARKET, BY REGION, 2020–2027 (USD MILLION) 112
TABLE 51 NORTH AMERICA: PULSE OXIMETERS MARKET, BY COUNTRY, 
2020–2027 (USD MILLION) 112
TABLE 52 EUROPE: PULSE OXIMETERS MARKET, BY COUNTRY, 
2020–2027 (USD MILLION) 112
TABLE 53 ASIA PACIFIC: PULSE OXIMETERS MARKET, BY COUNTRY, 
2020–2027 (USD MILLION) 113
TABLE 54 ROW: PULSE OXIMETERS MARKET, BY REGION, 2020–2027 (USD MILLION) 113
6.3.2.5 Peak flow meters 113
6.3.2.5.1 Technological advancements and growing awareness are driving the growth of this market segment 113
TABLE 55 PEAK FLOW METERS MARKET, BY REGION, 2020–2027 (USD MILLION) 114
TABLE 56 NORTH AMERICA: PEAK FLOW METERS MARKET, BY COUNTRY, 
2020–2027 (USD MILLION) 114
TABLE 57 EUROPE: PEAK FLOW METERS MARKET, BY COUNTRY, 
2020–2027 (USD MILLION) 114
TABLE 58 ASIA PACIFIC: PEAK FLOW METERS MARKET, BY COUNTRY, 
2020–2027 (USD MILLION) 115
TABLE 59 ROW: PEAK FLOW METERS MARKET, BY REGION, 2020–2027 (USD MILLION) 115
6.3.2.6 ECG monitors 115
6.3.2.6.1 Rising incidence of CVD driving the demand for ECG monitors 115
TABLE 60 ECG MONITORS MARKET, BY REGION, 2020–2027 (USD MILLION) 115
TABLE 61 NORTH AMERICA: ECG MONITORS MARKET, BY COUNTRY, 
2020–2027 (USD MILLION) 116
TABLE 62 EUROPE: ECG MONITORS MARKET, BY COUNTRY, 
2020–2027 (USD MILLION) 116
TABLE 63 ASIA PACIFIC: ECG MONITORS MARKET, BY COUNTRY, 
2020–2027 (USD MILLION) 116
TABLE 64 ROW: ECG MONITORS MARKET, BY REGION, 2020–2027 (USD MILLION) 117
6.3.2.7 Other medical peripheral devices 117
TABLE 65 OTHER TELEHEALTH AND TELEMEDICINE PRODUCTS OFFERED 
BY MARKET PLAYERS 117
TABLE 66 OTHER MEDICAL PERIPHERAL DEVICES MARKET, BY REGION, 
2020–2027 (USD MILLION) 117
TABLE 67 NORTH AMERICA: OTHER MEDICAL PERIPHERAL DEVICES MARKET, 
BY COUNTRY, 2020–2027 (USD MILLION) 118
TABLE 68 EUROPE: OTHER MEDICAL PERIPHERAL DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 118
TABLE 69 ASIA PACIFIC: OTHER MEDICAL PERIPHERAL DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 118
TABLE 70 ROW: OTHER MEDICAL PERIPHERAL DEVICES MARKET, BY REGION, 
2020–2027 (USD MILLION) 119
7 TELEHEALTH AND TELEMEDICINE MARKET, BY MODE OF DELIVERY 120
7.1 INTRODUCTION 121
TABLE 71 TELEHEALTH AND TELEMEDICINE MARKET, BY MODE OF DELIVERY, 
2020–2027 (USD MILLION) 121
7.2 CLOUD-BASED MODE OF DELIVERY 121
7.2.1 CLOUD-BASED SOLUTIONS TO DOMINATE THE MARKET DURING 
THE FORECAST PERIOD 121
TABLE 72 CLOUD-BASED TELEHEALTH AND TELEMEDICINE MARKET, BY REGION, 2020–2027 (USD MILLION) 122
TABLE 73 NORTH AMERICA: CLOUD-BASED TELEHEALTH AND TELEMEDICINE MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 122
TABLE 74 EUROPE: CLOUD-BASED TELEHEALTH AND TELEMEDICINE MARKET, 
BY COUNTRY, 2020–2027 (USD MILLION) 122
TABLE 75 ASIA PACIFIC: CLOUD-BASED TELEHEALTH AND TELEMEDICINE MARKET, 
BY COUNTRY, 2020–2027 (USD MILLION) 123
TABLE 76 ROW: CLOUD-BASED TELEHEALTH AND TELEMEDICINE MARKET, BY REGION, 2020–2027 (USD MILLION) 123
7.3 ON-PREMISE MODE OF DELIVERY 123
7.3.1 ON-PREMISE SOLUTIONS PROVIDE ENHANCED CONTROL OF SOFTWARE AND ALLOW REUSE OF EXISTING INFRASTRUCTURE 123
TABLE 77 ON-PREMISE TELEHEALTH AND TELEMEDICINE MARKET, BY REGION, 
2020–2027 (USD MILLION) 124
TABLE 78 NORTH AMERICA: ON-PREMISE TELEHEALTH AND TELEMEDICINE MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 124
TABLE 79 EUROPE: ON-PREMISE TELEHEALTH AND TELEMEDICINE MARKET, 
BY COUNTRY, 2020–2027 (USD MILLION) 124
TABLE 80 ASIA PACIFIC: ON-PREMISE TELEHEALTH AND TELEMEDICINE MARKET, 
BY COUNTRY, 2020–2027 (USD MILLION) 125
TABLE 81 ROW: ON-PREMISE TELEHEALTH AND TELEMEDICINE MARKET, BY REGION, 2020–2027 (USD MILLION) 125
8 TELEHEALTH AND TELEMEDICINE MARKET, BY APPLICATION 126
8.1 INTRODUCTION 127
TABLE 82 TELEHEALTH AND TELEMEDICINE MARKET, BY APPLICATION, 
2020–2027 (USD MILLION) 127
8.2 TELECONSULTATION 127
8.2.1 SHORTAGE OF PHYSICIANS TO DRIVE THE MARKET GROWTH FOR TELECONSULTATION SOLUTIONS 127
TABLE 83 TELECONSULTATION MARKET, BY REGION, 2020–2027 (USD MILLION) 128
TABLE 84 NORTH AMERICA: TELECONSULTATION MARKET, BY COUNTRY, 
2020–2027 (USD MILLION) 128
TABLE 85 EUROPE: TELECONSULTATION MARKET, BY COUNTRY, 
2020–2027 (USD MILLION) 128
TABLE 86 ASIA PACIFIC: TELECONSULTATION MARKET, BY COUNTRY, 
2020–2027 (USD MILLION) 129
TABLE 87 ROW: TELECONSULTATION MARKET, BY REGION, 2020–2027 (USD MILLION) 129
8.3 TELEICU 129
8.3.1 RISING EMERGENCY VISITS, AGING POPULATION, AND PERSONNEL SHORTAGE IN RURAL AREAS SUPPORTS THE GROWTH OF THIS SEGMENT 129
TABLE 88 TELEICU MARKET, BY REGION, 2020–2027 (USD MILLION) 130
TABLE 89 NORTH AMERICA: TELEICU MARKET, BY COUNTRY, 
2020–2027 (USD MILLION) 130
TABLE 90 EUROPE: TELEICU MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 131
TABLE 91 ASIA PACIFIC: TELEICU MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 131
TABLE 92 ROW: TELEICU MARKET, BY REGION, 2020–2027 (USD MILLION) 131
8.4 TELEPSYCHIATRY 132
8.4.1 SHORTAGE OF MENTAL HEALTH PRACTITIONERS AND FAVORABLE REIMBURSEMENT SCENARIO TO DRIVE THE MARKET GROWTH 132
TABLE 93 TELEPSYCHIATRY MARKET, BY REGION, 2020–2027 (USD MILLION) 132
TABLE 94 NORTH AMERICA: TELEPSYCHIATRY MARKET, BY COUNTRY, 
2020–2027 (USD MILLION) 133
TABLE 95 EUROPE: TELEPSYCHIATRY MARKET, BY COUNTRY, 
2020–2027 (USD MILLION) 133
TABLE 96 ASIA PACIFIC: TELEPSYCHIATRY MARKET, BY COUNTRY, 
2020–2027 (USD MILLION) 133
TABLE 97 ROW: TELEPSYCHIATRY MARKET, BY REGION, 2020–2027 (USD MILLION) 134
8.5 TELERADIOLOGY 134
8.5.1 TELERADIOLOGY TO ACCOUNT FOR THE LARGEST SHARE OF THE TELEHEALTH AND TELEMEDICINE MARKET DURING THE FORECAST PERIOD 134
TABLE 98 TELERADIOLOGY MARKET, BY REGION, 2020–2027 (USD MILLION) 135
TABLE 99 NORTH AMERICA: TELERADIOLOGY MARKET, BY COUNTRY, 
2020–2027 (USD MILLION) 135
TABLE 100 EUROPE: TELERADIOLOGY MARKET, BY COUNTRY, 
2020–2027 (USD MILLION) 135
TABLE 101 ASIA PACIFIC: TELERADIOLOGY MARKET, BY COUNTRY, 
2020–2027 (USD MILLION) 136
TABLE 102 ROW: TELERADIOLOGY MARKET, BY REGION, 2020–2027 (USD MILLION) 136
8.6 TELESTROKE 136
8.6.1 RISING STROKE INCIDENCE AND A SHORTAGE OF SPECIALISTS TO SUPPORT THE GROWTH OF THIS SEGMENT 136
TABLE 103 TELESTROKE MARKET, BY REGION, 2020–2027 (USD MILLION) 137
TABLE 104 NORTH AMERICA: TELESTROKE MARKET, BY COUNTRY, 
2020–2027 (USD MILLION) 137
TABLE 105 EUROPE: TELESTROKE MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 137
TABLE 106 ASIA PACIFIC: TELESTROKE MARKET, BY COUNTRY, 
2020–2027 (USD MILLION) 138
TABLE 107 ROW: TELESTROKE MARKET, BY REGION, 2020–2027 (USD MILLION) 138
8.7 TELEDERMATOLOGY 138
8.7.1 WIDE USAGE OF HIGH-END CAMERAS HAVE SIGNIFICANTLY IMPROVED THE DIAGNOSIS OF SKIN DISEASES 138
TABLE 108 TELEDERMATOLOGY MARKET, BY REGION, 2020–2027 (USD MILLION) 139
TABLE 109 NORTH AMERICA: TELEDERMATOLOGY MARKET, BY COUNTRY, 
2020–2027 (USD MILLION) 139
TABLE 110 EUROPE: TELEDERMATOLOGY MARKET, BY COUNTRY, 
2020–2027 (USD MILLION) 139
TABLE 111 ASIA PACIFIC: TELEDERMATOLOGY MARKET, BY COUNTRY, 
2020–2027 (USD MILLION) 140
TABLE 112 ROW: TELEDERMATOLOGY MARKET, BY REGION, 2020–2027 (USD MILLION) 140
8.8 OTHER APPLICATIONS 140
TABLE 113 OTHER APPLICATIONS MARKET, BY REGION, 2020–2027 (USD MILLION) 140
TABLE 114 NORTH AMERICA: OTHER APPLICATIONS MARKET, BY COUNTRY, 
2020–2027 (USD MILLION) 141
TABLE 115 EUROPE: OTHER APPLICATIONS MARKET, BY COUNTRY, 
2020–2027 (USD MILLION) 141
TABLE 116 ASIA PACIFIC: OTHER APPLICATIONS MARKET, BY COUNTRY, 
2020–2027 (USD MILLION) 141
TABLE 117 ROW: OTHER APPLICATIONS MARKET, BY REGION, 
2020–2027 (USD MILLION) 142
9 TELEHEALTH AND TELEMEDICINE MARKET, BY END USER 143
9.1 INTRODUCTION 144
TABLE 118 TELEHEALTH AND TELEMEDICINE MARKET, BY END USER, 
2020–2027 (USD MILLION) 144
9.2 PROVIDERS 144
9.2.1 THE INCREASING NUMBER OF TELE-SPECIALTY SERVICES OFFERED 
BY PROVIDERS IS EXPECTED TO DRIVE THE GROWTH OF THIS END-USER SEGMENT 144
TABLE 119 TELEHEALTH AND TELEMEDICINE MARKET FOR PROVIDERS, BY REGION, 2020–2027 (USD MILLION) 145
TABLE 120 NORTH AMERICA: TELEHEALTH AND TELEMEDICINE MARKET FOR PROVIDERS, BY COUNTRY, 2020–2027 (USD MILLION) 145
TABLE 121 EUROPE: TELEHEALTH AND TELEMEDICINE MARKET FOR PROVIDERS, 
BY COUNTRY, 2020–2027 (USD MILLION) 145
TABLE 122 ASIA PACIFIC: TELEHEALTH AND TELEMEDICINE MARKET FOR PROVIDERS, 
BY COUNTRY, 2020–2027 (USD MILLION) 146
TABLE 123 ROW: TELEHEALTH AND TELEMEDICINE MARKET FOR PROVIDERS, 
BY REGION, 2020–2027 (USD MILLION) 146
9.3 PAYERS 146
9.3.1 TELEHEALTH AND TELEMEDICINE ENABLE PAYERS TO REDUCE PATIENT READMISSIONS AND OVERHEAD COSTS 146
TABLE 124 TELEHEALTH AND TELEMEDICINE MARKET FOR PAYERS, BY REGION, 
2020–2027 (USD MILLION) 147
TABLE 125 NORTH AMERICA: TELEHEALTH AND TELEMEDICINE MARKET FOR PAYERS, 
BY COUNTRY, 2020–2027 (USD MILLION) 147
TABLE 126 EUROPE: TELEHEALTH AND TELEMEDICINE MARKET FOR PAYERS, 
BY COUNTRY, 2020–2027 (USD MILLION) 148
TABLE 127 ASIA PACIFIC: TELEHEALTH AND TELEMEDICINE MARKET FOR PAYERS, 
BY COUNTRY, 2020–2027 (USD MILLION) 148
TABLE 128 ROW: TELEHEALTH AND TELEMEDICINE MARKET FOR PAYERS, BY REGION, 2020–2027 (USD MILLION) 148
9.4 PATIENTS 149
9.4.1 RISING DISEASE PREVALENCE AND THE EMERGENCE OF ADVANCED WEARABLE MONITORS TO SUPPORT THE DEMAND FOR TELEHEALTH SOLUTIONS AMONG PATIENTS 149
TABLE 129 TELEHEALTH AND TELEMEDICINE MARKET FOR PATIENTS, BY REGION, 
2020–2027 (USD MILLION) 149
TABLE 130 NORTH AMERICA: TELEHEALTH AND TELEMEDICINE MARKET FOR PATIENTS, BY COUNTRY, 2020–2027 (USD MILLION) 150
TABLE 131 EUROPE: TELEHEALTH AND TELEMEDICINE MARKET FOR PATIENTS, 
BY COUNTRY, 2020–2027 (USD MILLION) 150
TABLE 132 ASIA PACIFIC: TELEHEALTH AND TELEMEDICINE MARKET FOR PATIENTS, 
BY COUNTRY, 2020–2027 (USD MILLION) 150
TABLE 133 ROW: TELEHEALTH AND TELEMEDICINE MARKET FOR PATIENTS, BY REGION, 2020–2027 (USD MILLION) 151
9.5 OTHER END USERS 151
TABLE 134 TELEHEALTH AND TELEMEDICINE MARKET FOR OTHER END USERS, 
BY REGION, 2020–2027 (USD MILLION) 151
TABLE 135 NORTH AMERICA: TELEHEALTH AND TELEMEDICINE MARKET FOR OTHER 
END USERS, BY COUNTRY, 2020–2027 (USD MILLION) 152
TABLE 136 EUROPE: TELEHEALTH AND TELEMEDICINE MARKET FOR OTHER END USERS, BY COUNTRY, 2020–2027 (USD MILLION) 152
TABLE 137 ASIA PACIFIC: TELEHEALTH AND TELEMEDICINE MARKET FOR OTHER 
END USERS, BY COUNTRY, 2020–2027 (USD MILLION) 152
TABLE 138 ROW: TELEHEALTH AND TELEMEDICINE MARKET FOR OTHER END USERS, 
BY REGION, 2020–2027 (USD MILLION) 153
10 TELEHEALTH AND TELEMEDICINE MARKET, BY REGION 154
10.1 INTRODUCTION 155
TABLE 139 TELEHEALTH AND TELEMEDICINE MARKET, BY REGION, 
2020–2027 (USD MILLION) 155
10.2 NORTH AMERICA 155
FIGURE 22 NORTH AMERICA: TELEHEALTH AND TELEMEDICINE MARKET SNAPSHOT 156
TABLE 140 NORTH AMERICA: TELEHEALTH AND TELEMEDICINE MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 157
TABLE 141 NORTH AMERICA: TELEHEALTH AND TELEMEDICINE MARKET, 
BY COMPONENT, 2020–2027 (USD MILLION) 157
TABLE 142 NORTH AMERICA: TELEHEALTH AND TELEMEDICINE SOFTWARE & SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 157
TABLE 143 NORTH AMERICA: TELEHEALTH AND TELEMEDICINE HARDWARE MARKET, 
BY TYPE, 2020–2027 (USD MILLION) 158
TABLE 144 NORTH AMERICA: TELEHEALTH AND TELEMEDICINE MEDICAL PERIPHERAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 158
TABLE 145 NORTH AMERICA: TELEHEALTH AND TELEMEDICINE MARKET, 
BY MODE OF DELIVERY, 2020–2027 (USD MILLION) 158
TABLE 146 NORTH AMERICA: TELEHEALTH AND TELEMEDICINE MARKET, 
BY APPLICATION, 2020–2027 (USD MILLION) 159
TABLE 147 NORTH AMERICA: TELEHEALTH AND TELEMEDICINE MARKET, BY END USER, 2020–2027 (USD MILLION) 159
10.2.1 US 159
10.2.1.1 Favorable regulations and the availability of funding and support for telehealth to drive the market in the US 159
TABLE 148 US: TELEHEALTH AND TELEMEDICINE MARKET, BY COMPONENT, 
2020–2027 (USD MILLION) 161
TABLE 149 US: TELEHEALTH AND TELEMEDICINE SOFTWARE & SERVICES MARKET, 
BY TYPE, 2020–2027 (USD MILLION) 161
TABLE 150 US: TELEHEALTH AND TELEMEDICINE HARDWARE MARKET, BY TYPE, 
2020–2027 (USD MILLION) 162
TABLE 151 US: TELEHEALTH AND TELEMEDICINE MEDICAL PERIPHERAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 162
TABLE 152 US: TELEHEALTH AND TELEMEDICINE MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION) 162
TABLE 153 US: TELEHEALTH AND TELEMEDICINE MARKET, BY APPLICATION, 
2020–2027 (USD MILLION) 163
TABLE 154 US: TELEHEALTH AND TELEMEDICINE MARKET, BY END USER, 
2020–2027 (USD MILLION) 163
10.2.2 CANADA 163
10.2.2.1 Increasing collaborations and efforts to promote the adoption of telehealth and telemedicine to drive market growth in Canada 163
TABLE 155 CANADA: TELEHEALTH AND TELEMEDICINE MARKET, BY COMPONENT, 
2020–2027 (USD MILLION) 164
TABLE 156 CANADA: TELEHEALTH AND TELEMEDICINE SOFTWARE & SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 165
TABLE 157 CANADA: TELEHEALTH AND TELEMEDICINE HARDWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 165
TABLE 158 CANADA: TELEHEALTH AND TELEMEDICINE MEDICAL PERIPHERAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 165
TABLE 159 CANADA: TELEHEALTH AND TELEMEDICINE MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION) 166
TABLE 160 CANADA: TELEHEALTH AND TELEMEDICINE MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 166
TABLE 161 CANADA: TELEHEALTH AND TELEMEDICINE MARKET, BY END USER, 
2020–2027 (USD MILLION) 166
10.3 EUROPE 167
TABLE 162 EUROPE: TELEHEALTH AND TELEMEDICINE MARKET, BY COUNTRY, 
2020–2027 (USD MILLION) 167
TABLE 163 EUROPE: TELEHEALTH AND TELEMEDICINE MARKET, BY COMPONENT, 
2020–2027 (USD MILLION) 168
TABLE 164 EUROPE: TELEHEALTH AND TELEMEDICINE SOFTWARE & SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 168
TABLE 165 EUROPE: TELEHEALTH AND TELEMEDICINE HARDWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 168
TABLE 166 EUROPE: TELEHEALTH AND TELEMEDICINE MEDICAL PERIPHERAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 169
TABLE 167 EUROPE: TELEHEALTH AND TELEMEDICINE MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION) 169
TABLE 168 EUROPE: TELEHEALTH AND TELEMEDICINE MARKET, BY APPLICATION, 
2020–2027 (USD MILLION) 170
TABLE 169 EUROPE: TELEHEALTH AND TELEMEDICINE MARKET, BY END USER, 
2020–2027 (USD MILLION) 170
10.3.1 GERMANY 170
10.3.1.1 Rapid digitization of healthcare systems and the rise in the geriatric population are driving market growth 170
TABLE 170 GERMANY: TELEHEALTH AND TELEMEDICINE MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 171
TABLE 171 GERMANY: TELEHEALTH AND TELEMEDICINE SOFTWARE & SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 172
TABLE 172 GERMANY: TELEHEALTH AND TELEMEDICINE HARDWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 172
TABLE 173 GERMANY: TELEHEALTH AND TELEMEDICINE MEDICAL PERIPHERAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 172
TABLE 174 GERMANY: TELEHEALTH AND TELEMEDICINE MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION) 173
TABLE 175 GERMANY: TELEHEALTH AND TELEMEDICINE MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 173
TABLE 176 GERMANY: TELEHEALTH AND TELEMEDICINE MARKET, BY END USER, 
2020–2027 (USD MILLION) 173
10.3.2 FRANCE 174
10.3.2.1 Favorable reimbursement and investment scenario for telehealth has supported the market in France 174
TABLE 177 FRANCE: TELEHEALTH AND TELEMEDICINE MARKET, BY COMPONENT, 
2020–2027 (USD MILLION) 175
TABLE 178 FRANCE: TELEHEALTH AND TELEMEDICINE SOFTWARE & SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 175
TABLE 179 FRANCE: TELEHEALTH AND TELEMEDICINE HARDWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 175
TABLE 180 FRANCE: TELEHEALTH AND TELEMEDICINE MEDICAL PERIPHERAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 176
TABLE 181 FRANCE: TELEHEALTH AND TELEMEDICINE MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION) 176
TABLE 182 FRANCE: TELEHEALTH AND TELEMEDICINE MARKET, BY APPLICATION, 
2020–2027 (USD MILLION) 177
TABLE 183 FRANCE: TELEHEALTH AND TELEMEDICINE MARKET, BY END USER, 
2020–2027 (USD MILLION) 177
10.3.3 UK 177
10.3.3.1 Need to manage increasing healthcare expenditures and a severe shortage of physicians have boosted the adoption of telehealth 177
TABLE 184 UK: TELEHEALTH AND TELEMEDICINE MARKET, BY COMPONENT, 
2020–2027 (USD MILLION) 178
TABLE 185 UK: TELEHEALTH AND TELEMEDICINE SOFTWARE & SERVICES MARKET, 
BY TYPE, 2020–2027 (USD MILLION) 179
TABLE 186 UK: TELEHEALTH AND TELEMEDICINE HARDWARE MARKET, BY TYPE, 
2020–2027 (USD MILLION) 179
TABLE 187 UK: TELEHEALTH AND TELEMEDICINE MEDICAL PERIPHERAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 179
TABLE 188 UK: TELEHEALTH AND TELEMEDICINE MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION) 180
TABLE 189 UK: TELEHEALTH AND TELEMEDICINE MARKET, BY APPLICATION, 
2020–2027 (USD MILLION) 180
TABLE 190 UK: TELEHEALTH AND TELEMEDICINE MARKET, BY END USER, 
2020–2027 (USD MILLION) 180
10.3.4 ITALY 181
10.3.4.1 Established telehealth and telespecialty practices and high density of aging population drive market growth in Italy 181
TABLE 191 ITALY: TELEHEALTH AND TELEMEDICINE MARKET, BY COMPONENT, 
2020–2027 (USD MILLION) 182
TABLE 192 ITALY: TELEHEALTH AND TELEMEDICINE SOFTWARE & SERVICES MARKET, 
BY TYPE, 2020–2027 (USD MILLION) 182
TABLE 193 ITALY: TELEHEALTH AND TELEMEDICINE HARDWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 182
TABLE 194 ITALY: TELEHEALTH AND TELEMEDICINE MEDICAL PERIPHERAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 183
TABLE 195 ITALY: TELEHEALTH AND TELEMEDICINE MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION) 183
TABLE 196 ITALY: TELEHEALTH AND TELEMEDICINE MARKET, BY APPLICATION, 
2020–2027 (USD MILLION) 184
TABLE 197 ITALY: TELEHEALTH AND TELEMEDICINE MARKET, BY END USER, 
2020–2027 (USD MILLION) 184
10.3.5 SPAIN 184
10.3.5.1 Well-organized and efficient healthcare system indicates opportunities for telehealth adoption 184
TABLE 198 SPAIN: TELEHEALTH AND TELEMEDICINE MARKET, BY COMPONENT, 
2020–2027 (USD MILLION) 185
TABLE 199 SPAIN: TELEHEALTH AND TELEMEDICINE SOFTWARE & SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 185
TABLE 200 SPAIN: TELEHEALTH AND TELEMEDICINE HARDWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 185
TABLE 201 SPAIN: TELEHEALTH AND TELEMEDICINE MEDICAL PERIPHERAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 186
TABLE 202 SPAIN: TELEHEALTH AND TELEMEDICINE MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION) 186
TABLE 203 SPAIN: TELEHEALTH AND TELEMEDICINE MARKET, BY APPLICATION, 
2020–2027 (USD MILLION) 187
TABLE 204 SPAIN: TELEHEALTH AND TELEMEDICINE MARKET, BY END USER, 
2020–2027 (USD MILLION) 187
10.3.6 REST OF EUROPE 187
TABLE 205 ROE: TELEHEALTH AND TELEMEDICINE MARKET, BY COMPONENT, 
2020–2027 (USD MILLION) 188
TABLE 206 ROE: TELEHEALTH AND TELEMEDICINE SOFTWARE & SERVICES MARKET, 
BY TYPE, 2020–2027 (USD MILLION) 188
TABLE 207 ROE: TELEHEALTH AND TELEMEDICINE HARDWARE MARKET, BY TYPE, 
2020–2027 (USD MILLION) 189
TABLE 208 ROE: TELEHEALTH AND TELEMEDICINE MEDICAL PERIPHERAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 189
TABLE 209 ROE: TELEHEALTH AND TELEMEDICINE MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION) 189
TABLE 210 ROE: TELEHEALTH AND TELEMEDICINE MARKET, BY APPLICATION, 
2020–2027 (USD MILLION) 190
TABLE 211 ROE: TELEHEALTH AND TELEMEDICINE MARKET, BY END USER, 
2020–2027 (USD MILLION) 190
10.4 ASIA PACIFIC 191
FIGURE 23 APAC: TELEHEALTH AND TELEMEDICINE MARKET SNAPSHOT 192
TABLE 212 ASIA PACIFIC: TELEHEALTH AND TELEMEDICINE MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 193
TABLE 213 ASIA PACIFIC: TELEHEALTH AND TELEMEDICINE MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 193
TABLE 214 ASIA PACIFIC: TELEHEALTH AND TELEMEDICINE SOFTWARE & SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 193
TABLE 215 ASIA PACIFIC: TELEHEALTH AND TELEMEDICINE HARDWARE MARKET, 
BY TYPE, 2020–2027 (USD MILLION) 194
TABLE 216 ASIA PACIFIC: TELEHEALTH AND TELEMEDICINE MEDICAL PERIPHERAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 194
TABLE 217 ASIA PACIFIC: TELEHEALTH AND TELEMEDICINE MARKET, 
BY MODE OF DELIVERY, 2020–2027 (USD MILLION) 194
TABLE 218 ASIA PACIFIC: TELEHEALTH AND TELEMEDICINE MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 195
TABLE 219 ASIA PACIFIC: TELEHEALTH AND TELEMEDICINE MARKET, BY END USER, 2020–2027 (USD MILLION) 195
10.4.1 CHINA 195
10.4.1.1 China to account for the largest share of the APAC telehealth and telemedicine market 195
TABLE 220 CHINA: TELEHEALTH AND TELEMEDICINE MARKET, BY COMPONENT, 
2020–2027 (USD MILLION) 196
TABLE 221 CHINA: TELEHEALTH AND TELEMEDICINE SOFTWARE & SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 196
TABLE 222 CHINA: TELEHEALTH AND TELEMEDICINE HARDWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 197
TABLE 223 CHINA: TELEHEALTH AND TELEMEDICINE MEDICAL PERIPHERAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 197
TABLE 224 CHINA: TELEHEALTH AND TELEMEDICINE MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION) 197
TABLE 225 CHINA: TELEHEALTH AND TELEMEDICINE MARKET, BY APPLICATION, 
2020–2027 (USD MILLION) 198
TABLE 226 CHINA: TELEHEALTH AND TELEMEDICINE MARKET, BY END USER, 
2020–2027 (USD MILLION) 198
10.4.2 JAPAN 198
10.4.2.1 Universal healthcare coverage, well-established insurance system, and strong infrastructure make Japan a prominent market in APAC 198
TABLE 227 JAPAN: TELEHEALTH AND TELEMEDICINE MARKET, BY COMPONENT, 
2020–2027 (USD MILLION) 199
TABLE 228 JAPAN: TELEHEALTH AND TELEMEDICINE SOFTWARE & SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 200
TABLE 229 JAPAN: TELEHEALTH AND TELEMEDICINE HARDWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 200
TABLE 230 JAPAN: TELEHEALTH AND TELEMEDICINE MEDICAL PERIPHERAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 200
TABLE 231 JAPAN: TELEHEALTH AND TELEMEDICINE MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION) 201
TABLE 232 JAPAN: TELEHEALTH AND TELEMEDICINE MARKET, BY APPLICATION, 
2020–2027 (USD MILLION) 201
TABLE 233 JAPAN: TELEHEALTH AND TELEMEDICINE MARKET, BY END USER, 
2020–2027 (USD MILLION) 201
10.4.3 INDIA 202
10.4.3.1 Favorable government policies and high density of rural population to support market growth in India 202
TABLE 234 INDIA: TELEHEALTH AND TELEMEDICINE MARKET, BY COMPONENT, 
2020–2027 (USD MILLION) 203
TABLE 235 INDIA: TELEHEALTH AND TELEMEDICINE SOFTWARE & SERVICES MARKET, 
BY TYPE, 2020–2027 (USD MILLION) 203
TABLE 236 INDIA: TELEHEALTH AND TELEMEDICINE HARDWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 203
TABLE 237 INDIA: TELEHEALTH AND TELEMEDICINE MEDICAL PERIPHERAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 204
TABLE 238 INDIA: TELEHEALTH AND TELEMEDICINE MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION) 204
TABLE 239 INDIA: TELEHEALTH AND TELEMEDICINE MARKET, BY APPLICATION, 
2020–2027 (USD MILLION) 205
TABLE 240 INDIA: TELEHEALTH AND TELEMEDICINE MARKET, BY END USER, 
2020–2027 (USD MILLION) 205
10.4.4 AUSTRALIA 205
10.4.4.1 The popularity of telehealth and telemedicine is growing in Australia 205
TABLE 241 AUSTRALIA: TELEHEALTH AND TELEMEDICINE MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 206
TABLE 242 AUSTRALIA: TELEHEALTH AND TELEMEDICINE SOFTWARE & SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 206
TABLE 243 AUSTRALIA: TELEHEALTH AND TELEMEDICINE HARDWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 207
TABLE 244 AUSTRALIA: TELEHEALTH AND TELEMEDICINE MEDICAL PERIPHERAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 207
TABLE 245 AUSTRALIA: TELEHEALTH AND TELEMEDICINE MARKET, 
BY MODE OF DELIVERY, 2020–2027 (USD MILLION) 207
TABLE 246 AUSTRALIA: TELEHEALTH AND TELEMEDICINE MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 208
TABLE 247 AUSTRALIA: TELEHEALTH AND TELEMEDICINE MARKET, BY END USER, 
2020–2027 (USD MILLION) 208
10.4.5 REST OF ASIA PACIFIC 208
TABLE 248 ROAPAC: TELEHEALTH AND TELEMEDICINE MARKET, BY COMPONENT, 
2020–2027 (USD MILLION) 209
TABLE 249 ROAPAC: TELEHEALTH AND TELEMEDICINE SOFTWARE & SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 209
TABLE 250 ROAPAC: TELEHEALTH AND TELEMEDICINE HARDWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 210
TABLE 251 ROAPAC: TELEHEALTH AND TELEMEDICINE MEDICAL PERIPHERAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 210
TABLE 252 ROAPAC: TELEHEALTH AND TELEMEDICINE MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION) 210
TABLE 253 ROAPAC: TELEHEALTH AND TELEMEDICINE MARKET, BY APPLICATION, 
2020–2027 (USD MILLION) 211
TABLE 254 ROAPAC: TELEHEALTH AND TELEMEDICINE MARKET, BY END USER, 
2020–2027 (USD MILLION) 211
10.5 REST OF THE WORLD 212
TABLE 255 ROW: TELEHEALTH AND TELEMEDICINE MARKET, BY REGION, 
2020–2027 (USD MILLION) 212
TABLE 256 ROW: TELEHEALTH AND TELEMEDICINE MARKET, BY COMPONENT, 
2020–2027 (USD MILLION) 212
TABLE 257 ROW: TELEHEALTH AND TELEMEDICINE SOFTWARE & SERVICES MARKET, 
BY TYPE, 2020–2027 (USD MILLION) 212
TABLE 258 ROW: TELEHEALTH AND TELEMEDICINE HARDWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 213
TABLE 259 ROW: TELEHEALTH AND TELEMEDICINE MEDICAL PERIPHERAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 213
TABLE 260 ROW: TELEHEALTH AND TELEMEDICINE MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION) 213
TABLE 261 ROW: TELEHEALTH AND TELEMEDICINE MARKET, BY APPLICATION, 
2020–2027 (USD MILLION) 214
TABLE 262 ROW: TELEHEALTH AND TELEMEDICINE MARKET, BY END USER, 
2020–2027 (USD MILLION) 214
10.5.1 LATIN AMERICA 214
10.5.1.1 Legislative changes, aging population, and uneven physician distribution will favor market growth in LATAM 214
TABLE 263 LATAM: TELEHEALTH AND TELEMEDICINE MARKET, BY COMPONENT, 
2020–2027 (USD MILLION) 215
TABLE 264 LATAM: TELEHEALTH AND TELEMEDICINE SOFTWARE & SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 216
TABLE 265 LATAM: TELEHEALTH AND TELEMEDICINE HARDWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 216
TABLE 266 LATAM: TELEHEALTH AND TELEMEDICINE MEDICAL PERIPHERAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 216
TABLE 267 LATAM: TELEHEALTH AND TELEMEDICINE MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION) 217
TABLE 268 LATAM: TELEHEALTH AND TELEMEDICINE MARKET, BY APPLICATION, 
2020–2027 (USD MILLION) 217
TABLE 269 LATAM: TELEHEALTH AND TELEMEDICINE MARKET, BY END USER, 
2020–2027 (USD MILLION) 217
10.5.2 MIDDLE EAST & AFRICA 218
10.5.2.1 Healthcare infrastructural development and government initiatives will drive the market in the MEA 218
TABLE 270 MEA: TELEHEALTH AND TELEMEDICINE MARKET, BY COMPONENT, 
2020–2027 (USD MILLION) 218
TABLE 271 MEA: TELEHEALTH AND TELEMEDICINE SOFTWARE & SERVICES MARKET, 
BY TYPE, 2020–2027 (USD MILLION) 219
TABLE 272 MEA: TELEHEALTH AND TELEMEDICINE HARDWARE MARKET, BY TYPE, 
2020–2027 (USD MILLION) 219
TABLE 273 MEA: TELEHEALTH AND TELEMEDICINE MEDICAL PERIPHERAL DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 219
TABLE 274 MEA: TELEHEALTH AND TELEMEDICINE MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION) 220
TABLE 275 MEA: TELEHEALTH AND TELEMEDICINE MARKET, BY APPLICATION, 
2020–2027 (USD MILLION) 220
TABLE 276 MEA: TELEHEALTH AND TELEMEDICINE MARKET, BY END USER, 
2020–2027 (USD MILLION) 220
11 COMPETITIVE LANDSCAPE 221
11.1 OVERVIEW 221
FIGURE 24 KEY DEVELOPMENTS OF PROMINENT PLAYERS OPERATING IN THE TELEHEALTH & TELEMEDICINE MARKET (2018–2021) 221
11.2 MARKET RANKING ANALYSIS 222
FIGURE 25 MARKET RANKING OF COMPANIES OPERATING IN THE TELEHEALTH & TELEMEDICINE MARKET (2021) 222
11.3 MARKET SHARE ANALYSIS 223
TABLE 277 TELEHEALTH & TELEMEDICINE MARKET: DEGREE OF COMPETITION 223
FIGURE 26 MARKET SHARE ANALYSIS: TELEHEALTH & TELEMEDICINE MARKET 223
11.4 COMPANY EVALUATION QUADRANT (OVERALL MARKET) 224
11.4.1 STARS 224
11.4.2 EMERGING LEADERS 224
11.4.3 PARTICIPANTS 224
11.4.4 PERVASIVE PLAYERS 224
FIGURE 27 TELEHEALTH & TELEMEDICINE MARKET: COMPANY EVALUATION QUADRANT, 2021 (OVERALL MARKET) 225
11.5 COMPANY EVALUATION QUADRANT FOR EMERGING PLAYERS 226
11.5.1 PROGRESSIVE COMPANIES 226
11.5.2 RESPONSIVE COMPANIES 226
11.5.3 STARTING BLOCKS 226
11.5.4 DYNAMIC COMPANIES 226
FIGURE 28 TELEHEALTH & TELEMEDICINE MARKET: COMPANY EVALUATION QUADRANT, 2021 (EMERGING PLAYERS) 227
11.6 COMPETITIVE BENCHMARKING 228
11.6.1 OVERALL COMPANY FOOTPRINT 228
TABLE 278 OVERALL COMPANY FOOTPRINT 228
11.7 COMPANY PRODUCT FOOTPRINT 229
TABLE 279 COMPANY PRODUCT FOOTPRINT 229
11.8 COMPANY REGIONAL FOOTPRINT 230
TABLE 280 COMPANY REGIONAL FOOTPRINT 230
11.9 COMPETITIVE SCENARIO 231
11.9.1 PRODUCT LAUNCHES & APPROVALS 231
TABLE 281 TELEHEALTH & TELEMEDICINE MARKET: KEY PRODUCT LAUNCHES & APPROVALS 231
11.9.2 DEALS 231
TABLE 282 TELEHEALTH & TELEMEDICINE MARKET: KEY DEALS 231
11.9.3 OTHER DEVELOPMENTS 232
TABLE 283 TELEHEALTH & TELEMEDICINE MARKET: OTHER KEY DEVELOPMENTS 232
12 COMPANY PROFILES 233
12.1 KEY PLAYERS 233
(Business overview, Products offered, Recent developments, MNM view)*
12.1.1 KONINKLIJKE PHILIPS 233
TABLE 284 KONINKLIJKE PHILIPS: BUSINESS OVERVIEW 233
FIGURE 29 KONINKLIJKE PHILIPS: COMPANY SNAPSHOT (2020) 234
12.1.2 MEDTRONIC 239
TABLE 285 MEDTRONIC: BUSINESS OVERVIEW 239
FIGURE 30 MEDTRONIC: COMPANY SNAPSHOT (2020) 240
12.1.3 GE HEALTHCARE 244
TABLE 286 GE HEALTHCARE: BUSINESS OVERVIEW 244
FIGURE 31 GE HEALTHCARE: COMPANY SNAPSHOT (2020) 245
12.1.4 CERNER CORPORATION 248
TABLE 287 CERNER CORPORATION: BUSINESS OVERVIEW 248
FIGURE 32 CERNER CORPORATION: COMPANY SNAPSHOT (2020) 249
12.1.5 SIEMENS HEALTHINEERS AG 252
TABLE 288 SIEMENS HEALTHINEERS: BUSINESS OVERVIEW 252
FIGURE 33 SIEMENS HEALTHINEERS: COMPANY SNAPSHOT (2020) 253
12.1.6 CISCO SYSTEMS 256
TABLE 289 CISCO SYSTEMS: BUSINESS OVERVIEW 256
FIGURE 34 CISCO SYSTEMS: COMPANY SNAPSHOT (2021) 257
12.1.7 ASAHI KASEI CORPORATION 259
TABLE 290 ASAHI KASEI CORPORATION: BUSINESS OVERVIEW 259
FIGURE 35 ASAHI KASEI CORPORATION: COMPANY SNAPSHOT (2020) 260
12.1.8 IRON BOW TECHNOLOGIES 262
TABLE 291 IRON BOW TECHNOLOGIES: BUSINESS OVERVIEW 262
12.1.9 AMERICAN WELL 264
TABLE 292 AMERICAN WELL: BUSINESS OVERVIEW 264
12.1.10 TELADOC HEALTH 268
TABLE 293 TELADOC HEALTH: BUSINESS OVERVIEW 268
FIGURE 36 TELADOC HEALTH: COMPANY SNAPSHOT (2020) 269
12.1.11 AMC HEALTH 272
TABLE 294 AMC HEALTH: BUSINESS OVERVIEW 272
12.1.12 TELESPECIALISTS 274
TABLE 295 TELESPECIALISTS: BUSINESS OVERVIEW 274
12.1.13 DOCTOR ON DEMAND, INC. 275
TABLE 296 DOCTOR ON DEMAND, INC.: BUSINESS OVERVIEW 275
12.1.14 MDLIVE 277
TABLE 297 MDLIVE: BUSINESS OVERVIEW 277
12.1.15 GLOBALMED 279
TABLE 298 GLOBALMED: BUSINESS OVERVIEW 279
12.1.16 MEDVIVO GROUP LTD. 281
TABLE 299 MEDVIVO GROUP LTD.: BUSINESS OVERVIEW 281
*Business overview, Products offered, Recent developments, MNM view might not be captured in case of unlisted companies.
12.2 OTHER PLAYERS 282
12.2.1 MEDWEB 282
12.2.2 VSEE 282
12.2.3 IMEDIPLUS 283
12.2.4 CHIRON HEALTH 283
12.2.5 ZIPNOSIS 284
12.2.6 ALTEN CALSOFT LABS (A SUBSIDIARY OF ALTEN GROUP) 284
12.2.7 ICLINIQ 285
12.2.8 PREVENTICE SOLUTIONS 285
12.2.9 RESIDEO LIFE CARE SOLUTIONS 286
13 APPENDIX 287
13.1 DISCUSSION GUIDE 287
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 292
13.3 AVAILABLE CUSTOMIZATIONS 294
13.4 RELATED REPORTS 294
13.5 AUTHOR DETAILS 295

 

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります


よくあるご質問


MarketsandMarkets社はどのような調査会社ですか?


マーケッツアンドマーケッツ(MarketsandMarkets)は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/07/04 10:27

162.47 円

175.74 円

209.86 円

ページTOPに戻る